A higher percentage of CD4+ T-lymphocytes expressing OX40 was observed among SLE patients (21.01% [6.50%]) as compared to controls (7.21% [2.12%])—(t=9.21, P<.01). The gene discussed is TNFRSF4; the disease is systemic lupus erythematosus.